AKRO - Bathi sadurunge bunga, pajak, lan amortisasi Akero Therapeutics, Inc.
Akero Therapeutics (AKRO) volatility is driven by the expansion of its flagship peptide for MASH therapy, while the net operating income before depreciation on GURU.Markets reflects business dynamics where the value of 0.00 serves as the current metric. Stability will be ensured by mass insurance reimbursement for innovations in liver treatment, and independent development without corporate mergers will minimize external risks.
Ringkesan rincian data analitis Akero (AKRO)
- kuotasi saiki lan rata-rata prakiraan nilai:
- statistik kapitalisasi pasar:
- data kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Akero Therapeutics|AKRO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Akero Therapeutics, Inc.|AKRO - Utang perusahaan|Rasio utang marang kapitalisasi buku Akero Therapeutics|AKRO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Akero Therapeutics|Koefisien jangkoan perantara akerotx.com
- rincian asil keuangan lan kelipatan valuasi:
AKRO - Bathi resik perusahaan|Bathi mangsa ngarep Akero Therapeutics|AKRO - Pangali P/E|Pangali Forward P/E akerotx.com|AKRO - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Akero Therapeutics|AKRO - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Akero Therapeutics|AKRO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan akerotx.com|AKRO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Akero Therapeutics
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis kabeh metrik perusahaan:Akero Corp (AKRO)
Absolute operating profit in cash captures the net cash flow from operating activities before depreciation and taxes, reflecting the efficiency of internal resource management. The current operating profit in cash at 0.00 confirms the R&D stage for Akero Therapeutics (AKRO), as the absence of commercial sales and the anticipation of Phase III trial results turn this metric into an indicator of the capital burn rate.
Karo sapa Akero Therapeutics saingan
ASND - Bathi operasional sadurunge ngurangi amortisasi|Madrigal Pharmaceuticals - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|MTSR: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MLTX (MoonLake Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA Crinetics Corp|Bathi operasional EBITDA NAMS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi SLNO (soleno.life)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Bathi sadurunge bunga, pajak, lan amortisasi|AGIO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GPCR: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MDXG: Bathi operasional EBITDA|RZLT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Altimmune Corp (ALT)|Bathi operasional sadurunge ngurangi amortisasi Aardvark Pharma AARD|Bathi operasional EBITDA SGMT (Sagimet Biosciences)|Bathi operasional EBITDA bioagelabs.com BIOA|BMEA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|QNCX - Bathi operasional EBITDA|GUTS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi vTv Therapeutics (VTVT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Agape ATP Corp|PLUR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Synlogic, Inc. (SYBX)|LPCN - Bathi sadurunge bunga, pajak, lan amortisasi|Matinas BioPharma Holdings - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SPRB|GLTO: Bathi operasional sadurunge ngurangi amortisasi|carmellrx.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|LUMO: Bathi operasional EBITDA|Organovo Holdings - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RDUS (Radius Health) - Bathi operasional EBITDA
